GIANT PHYLLODES TUMORS (BENIGN AND MALIGN VARIANT): CLINICAL CHANGES, SURGICAL TREATMENT AND AMBULATORY FOLLOW-UP – CASE REPORTS

  • Rosana Zabulon Feijó Belluco Especialista em Mastologia; Docente de medicina da Escola Superior de Ciências da Saúde – ESCS. Brasília, DF-BR http://orcid.org/0000-0003-2224-4690
  • Paulo Eduardo Silva Belluco Mestre em Ciências da Saúde pela Escola Superior de Ciências da Saúde – ESCS. Brasília, DF-BR http://orcid.org/0000-0002-5964-1107
  • Victor Hudson de Lacerda Borges Acadêmico de medicina da Escola Superior de Ciências da Saúde – ESCS. Brasília, DF-BR http://orcid.org/0000-0003-1729-7683
  • Rafaela Debastiani Garcia Especialista em Ginecologia e Obstetrícia – Hospital Regional da Asa Norte – HRAN. Brasília, DF-BR
  • Carla Borges Santos Especialista em Ginecologia e Obstetrícia – Hospital Regional da Asa Norte – HRAN. Brasília, DF-BR
  • Jullia Eduarda Feijó Belluco Acadêmica da faculdade de medicina – Centro Universitário Euro Americano – UNIEURO Brasília, DF-BR
  • Carmélia Matos Santiago Reis Doutora em Dermatologia pela Universidade Federal do Estado do Rio de Janeiro; Coordenadora da Pós –Graduação e Extensão da Escola Superior de Ciências da Saúde – ESCS – Brasília, DF-BR

Abstract

Phyloid Tumors are rare fibroepithelial tumors of the breast, representing less than 1% of all breast neoplasms, affecting women in the age group with the highest incidence between 40 and 50 years. With a variable biological behavior, the spectrum of benign presentation is confused with cellular fibroadenoma and, not the other extreme, the malignant presents similarities with other malignant neoplasms of the breast. Indicate, appear as a palpable, smooth, multinodular, firm, mobile and painless tumor, with abnormal mammographic and ultrasound findings. Tumor growth is usually rapid, with no correlation with increased risk of malignancy. The diagnosis is confirmed by histopathological evaluation. The treatment is eminently surgical, with excision with free margins and even mastectomy, a tumor-dependent extension being indicated. The presence of margins is important, since this contributes to the reduction of local recurrences, very common in this type of tumor. Adjuvant radiotherapy is controversial in the literature, but it appears to reduce recurrence without changing mortality. This article requires 02 cases of Phyloid Tumor, a benign and malignant variant, with which we aim to emphasize the importance of differential diagnosis and adequate surgical treatment, especially less postoperative morbidity.

Downloads

Download data is not yet available.

References

1. Chaney AW, Pollack A, McNeese MD, et al. Primary treatment of cystosarcoma phyllodes of the breast. Cancer 2000; 89:1502.

2. Reinfuss M, Mituś J, Duda K, et al. The treatment and prognosis of patients with phyllodes tumor of the breast: an analysis of 170 cases. Cancer 1996; 77:910.

3. Calhoun K, Allison KH, Kim JN, et al.. Phyllodes tumors. In: Diseases of the breast, Harris J, Lippman ME, Morrow M, Osborne KC (Eds), Lippincott Williams and Wilkins, 2014.

4. Tavassoli FA, Devilee P. and genetics of tumours of the breast and female genital organs. In: World Health Organization Classification of Tumours, IARC Press, Lyons 2003. p.99.

5. Strode M, Khoury T, Mangieri C, Takabe K. Update on the diagnosis and management of malignant phyllodes tumors of the breast. The Breast [Internet]. 2017 Jun;33:91–6.Available from: https://linkinghub.elsevier.com/retrie ve/pii/S0960977617300462

6. Karim RZ, Gerega SK, Yang YH, et al. Phyllodes tumours of the breast: a clinicopathological analysis of 65 cases from a single institution. Breast 2009; 18:165.

7. Zhou Z-R, Wang C-C, Yang Z-Z, Yu X-L, Guo X-M. Phyllodes tumors of the breast: diagnosis, treatment and prognostic factors related to recurrence. J Thorac Dis [Internet]. 2016 Nov;8(11):3361–8. Available from: http://jtd.amegroups.com/article/view/10314/9276

8. Tan BY, Acs G, Apple SK, Badve S, Bleiweiss IJ, Brogi E, et al. Phyllodes tumours of the breast: A consensus review. Histopathology. 2016;68(1):5–21.

9. Zhang Y, Kleer CG. Phyllodes Tumor of the Breast: Histopathologic Features, Differential Diagnosis, and Molecular/Genetic Updates. Arch Pathol Lab Med [Internet]. 2016 Jul 1;140(7):665–71. Available from: http://meridian.allenpress.com/aplm/article/140/7/665/65332/Phyllodes-Tumor-of-the-Breast-Histopathologic

10. Ogunbiyi S, Perry A, Jakate K, Simpson J, George R. Phyllodes tumour of the breast and margins: How much is enough? Can J Surg. 2019;62(1):E19–21.

11. Oprić S, Oprić D, Gugić D, Granić M. Phyllodes tumors and fibroadenoma common beginning and different ending. [Internet]. Vol. 36, Collegium antropologicum. 2012. p. 235–41. Available from: http://www.ncbi.nlm.nih.gov/pubme d/22816226

12. Toussaint A, Piaget-Rossel R, Stormacq C et al. Width of margins in phyllodes tumors of the breast the controversy drags on? – a systematic review and meta-analysis. Breast Cancer Res Treat. 2021 Jan:185(1):21-37

13. Wei Y, Yu Y, Ji Y, Zhong Y, Min N, Hu H, Guan Q, Li X. Surgical management in phyllodes tumors of the breast: a systematic review and meta-analysis. Gland Surg. 2022 Mar;11(3):513-523.
Published
2023-01-27
How to Cite
BELLUCO, Rosana Zabulon Feijó et al. GIANT PHYLLODES TUMORS (BENIGN AND MALIGN VARIANT): CLINICAL CHANGES, SURGICAL TREATMENT AND AMBULATORY FOLLOW-UP – CASE REPORTS. Revista Portuguesa de Cirurgia, [S.l.], n. 54, p. 83-89, jan. 2023. ISSN 2183-1165. Available at: <https://revista.spcir.com/index.php/spcir/article/view/892>. Date accessed: 12 july 2024. doi: https://doi.org/10.34635/rpc.892.
Section
Clinical Case